about
Epidemiology and risk profile of heart failureAortic wave dynamics and its influence on left ventricular workloadMyocardial Contrast Echocardiography in the Evaluation of Hypertensive Heart Disease.N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry.Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease.The heart failure epidemic.Epidemiology, aetiology, and prognosis of heart failure.Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.Advances in the treatment of congestive heart failure: new approaches for an old disease.Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (multi-ethnic study of atherosclerosis).Defects in insulin action in chronic heart failure.Patients with worsening chronic heart failure who present to a hospital emergency department require hospital carePreventable causative factors leading to hospital admission with decompensated heart failure.Survival differences between heart failure in general practices and in hospitals.Left ventricular dysfunction: causes, natural history, and hopes for reversal.Trends in comorbidity, disability, and polypharmacy in heart failureAssessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis.Gender and heart failure: a population perspectiveHypertension and heart failure: role of neurohormonal mechanisms.Residential exposure to traffic-related air pollution and survival after heart failure.Primary and secondary prevention of heart failure with statins.Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010Heart failure in South AsiaThe relationship between body mass index/body composition and survival in patients with heart failure.Genesis and regulation of the heart automaticity.Epidemiology of Heart Failure in Korea: Present and Future.Risk factors for heart failure: a population-based case-control study.Association of lipids with incident heart failure among adults with and without diabetes mellitus: Multiethnic Study of Atherosclerosis.Role of the angiotensin II receptor blocker valsartan in heart failure.PET and SPECT in heart failure.Mechanisms for cachexia in heart failure.Profile of St. Jude Medical's Allure Quadra quadripolar pacemaker system for cardiac resynchronization therapy.Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives.MitraClip and Transcatheter Aortic Valve Implantation (TAVI): State of the Art 2015.The role of dopaminergic agonists in congestive heart failure.Reduction of hospital days by biventricular pacing.Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure.
P2860
Q24630778-F71F62F3-E66D-4750-AF95-1267AD452A24Q28741508-EEC37147-1BFC-4E51-9C84-03BF623C249EQ30360279-E2A06CCE-4140-41A7-845C-8014010415ADQ30908647-04D30610-C94C-401E-8DE7-F65BD2DF8EE3Q33395934-C4E365F0-5CB0-472F-8E80-0B929A63D644Q33846667-D6627E14-CB16-4409-BA57-6ACD632B7701Q33858952-9218EB76-AAE7-4557-90EE-D5AB18A5B5E8Q33893882-B9DFC36B-0A0E-421E-A601-28F1C9B97B9AQ33962030-BBCF97DA-A56D-4BCA-B074-51042183FE60Q33977639-67AD8A4F-9DFE-4C0C-8912-A1855E6B6983Q34014145-538FCDAC-29E1-449B-BBB7-B9ED1EBAAF83Q34166305-FE2D6985-BA77-4703-B1C2-ACAAD4434A9EQ34188615-511650A3-2D63-4B09-A64D-00AB5D27E8E8Q35369642-123FE04A-BFCE-4AEC-B705-4AF98D3324B0Q35574257-A1871875-A204-4A77-B399-C8DD24D2B6B3Q35578952-0CD7578E-5BC4-4381-9479-A1974DDBB544Q35611459-B45D3B00-9473-4ED3-9B2D-D1F5109FEBEEQ35678102-6D11AED2-06F1-4C16-98B9-07134D102341Q35771154-0E1AF202-4D6F-499E-ACCB-7200E4AD625BQ36035785-5A425186-75F0-40E8-94A8-6723B4815338Q36535063-0EE3A4B3-3400-4380-A0D3-CC7D5E9E4AF8Q36686069-7D8175D9-0D8C-4E17-8BCF-800A1C8ADF1FQ36693904-CDFC9757-3D7B-4C06-A968-3818E5EAE02CQ36715249-73B92A7E-7065-4E60-B77F-CEF7DA897976Q36839088-4FB3F5F0-80A2-4C16-BED4-676ABC30E711Q36928506-F8BCE25A-47FE-4FB1-A9A6-076A02A757E7Q37202909-D6E786B6-231E-4FC1-8D38-C23ABB8AB077Q37216067-F7E63515-CA9F-4A15-AB6B-D6C69CC6E41DQ37318509-E073213C-DF81-4861-9ABB-DB9BD7156692Q37462115-F63B3C91-C1EE-4F3C-B8F8-442319AFFD11Q37710585-940C6CDF-B974-4203-B7E9-11556CE0E225Q37739210-7C5E8A18-ED94-4C54-9E57-55A48187C90BQ38075810-B3C11FC2-D53E-43B8-ABED-50C939454DFDQ38127358-957AF2E7-E59E-4365-A500-5CC22477DA22Q38270745-8F6242A3-4D7F-4908-BC68-1297BBE87E6FQ38912627-A95A7DFE-D9B9-4F6C-BF84-6C24C8A42A22Q40426241-5D1AD5A8-F483-45E4-8247-C65FEFFF56CEQ41348359-92FAEC75-1F98-4277-AF67-AACBAA2CCB4AQ42638829-57B97DB6-ED85-46BD-829D-BFA1AD04D6C5Q43661810-3EF3B5E0-DB2B-49D1-89DE-58B3B9FEF998
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Changing epidemiological features of cardiac failure.
@ast
Changing epidemiological features of cardiac failure.
@en
type
label
Changing epidemiological features of cardiac failure.
@ast
Changing epidemiological features of cardiac failure.
@en
prefLabel
Changing epidemiological features of cardiac failure.
@ast
Changing epidemiological features of cardiac failure.
@en
P2093
P2860
P1476
Changing epidemiological features of cardiac failure.
@en
P2093
P2860
P356
10.1136/HRT.72.2_SUPPL.S3
P433
P577
1994-08-01T00:00:00Z